Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“Rampant medical malpractices without any effective checks and balances are causing repeated outbreaks in Pakistan.”
Researchers broke down the various strategies that the gay men in the Opposites Attract study used to prevent HIV transmission.
Two gene-editing experts said Jiankui He’s actions were a “gross violation” of Chinese regulations and international standards.
Women in a global study began an HIV treatment regimen based on one of the two drugs after 20 weeks of gestation.
The study was conducted in Indonesia, Ukraine and Vietnam.
Listen to personal tales from the global urban AIDS response, including reports from five U.S. cities.
Ninety-six–week data from the Phase I/IIa trial showed the mosaic vaccine was safe and offered a broad and durable immune response.
The study of mixed-HIV-status gay couples prompted the CDC to conclude that undetectable people have effectively no risk of passing on HIV.
U.K. public health officials have expressed great concern over this latest sign of evolution of the sexually transmitted infection.
These rates are driven in large part by hepatitis B and C.
HIV scientists and advocates are waging a powerful war against the global epidemic.
Highlights from the research presented at the 9th International AIDS Society Conference on HIV Science in Paris.
But the median CD4 count at treatment start is below 350, which means work is needed to catch up to World Health Organization guidelines.
The country is urged to offer treatment to everyone who has HIV regardless of CD4 count; most cases are among young men.
The vaccine prompted a robust immune response against HIV in those without the virus; now researchers hope to move it into advanced trials.
The agency has issued an urgent call to nations to implement steps to ward off this threat to progress in fighting the epidemic.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.